Cardinal Health charts a technical range, shares sit between key support and resistance
27.06.2026 - 15:01:16 | ad-hoc-news.deBy Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-27, 15:00.
Cardinal Health (US14149Y1082) trades on the NYSE with the shares moving in a defined technical range between established support and resistance levels. Recent data show the stock closing at 237.92 US dollars on June 26, 2026, after a positive session with a 1.31 percent gain.
What recent trading shows
Cardinal Health shares closed at 237.92 US dollars on June 26, 2026, with the last print at 16:00 Eastern Time and a market capitalization around 55.7 billion US dollars. The price action that day spanned an intraday low of 236.00 dollars and a high of 240.44 dollars, according to price data collated by Robinhood and other quote platforms. The stock’s trailing price-to-earnings ratio sits in the mid-30s, with estimates around 35.9 to 36.2 times, underlining a valuation that reflects expectations for continued earnings progression. A recent Robinhood snapshot also notes a dividend yield just under 1 percent, giving the stock a modest income profile alongside its trading dynamics.
The technical picture today
Technical analysis from TradingKey places Cardinal Health’s current price momentum score at 9.75, ranking the shares 6th out of 157 names in the wider pharmaceuticals industry. The same analysis indicates the stock trading between a support level near 207.80 dollars and resistance around 254.24 dollars, framing the present 237.92 dollar price squarely within that range. Based on a suite of moving averages from five-day to 200-day spans, TradingKey identifies six buy signals and no sell signals, while the broader indicator set shows three buy signals against one sell signal, characterizing the technical stance as constructive. The site summarizes the configuration as suitable for range-bound swing trading, with the price oscillating between defined floors and ceilings rather than trending sharply. Additional quote aggregators such as Pandaforecast and Robinhood show similar price levels and volume readings for the latest session, reinforcing the data consistency across platforms.
Background and price data on Cardinal Health
Further news, historical performance figures and regulatory filings on Cardinal Health shares are available in the dedicated topic section and via the company’s investor relations page.
The business behind the stock
Cardinal Health generates most of its revenue from pharmaceutical distribution to hospitals, pharmacies and other healthcare providers across the United States and internationally, positioning it as one of the largest healthcare distributors globally. Recent coverage from Simply Wall St highlights that the company has been consistently beating earnings-per-share expectations while occasionally missing consensus revenue, showing stronger bottom-line discipline than top-line expansion. The same analysis notes Cardinal Health’s exposure to neonatal intensive care respiratory devices, a market projected to reach about 5.70 billion US dollars by 2035, giving the group a direct link to a growing clinical segment. In addition to distribution, Cardinal Health sells branded and private-label medical products ranging from surgical gloves and gowns to laboratory supplies, forming a second pillar that complements the core logistics and inventory management offering for healthcare systems.
Where the shares trade now
The Cardinal Health shares (US14149Y1082) trade on 2026-06-26 on the NYSE at 237.92 US dollars as of 16:00 Eastern Time.
Key data on the Cardinal Health shares
- Company: Cardinal Health Inc.
- ISIN: US14149Y1082
- WKN: 879230
- Ticker: CAH
- Trading venue: NYSE
- Price (as of 2026-06-26, 16:00): 237.92 US dollars
- Market cap: 55.7 billion US dollars (as of 2026-06-26)
- Sector / industry: Healthcare distribution / pharmaceuticals
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice, a recommendation or an offer to buy or sell any securities. Data and prices are based on sources cited in the text and may change over time.
